Beverage Hydration Index: Assessment of Four Rehydration Solutions
No studies to date to evaluate the effects of the three different liquid IV electrolyte products on the beverage hydration index (BHI). Therefore, the purpose of this study is to determine the impact of three different LIV products (Hydration multiplier, Sugar Free formulation with Amino Acids, and Sugar Free with allulose) on hydration status in young and active men and women compared to a control (water). The study will follow the same approach as used by Maughan and colleagues (2016) to measure the fluid balance (the difference between the amount of water consumed and passed as urine) and BHI (the relative amount of urine passed after consumption of a drink compared to water) including time in positive fluid balance, as well as determining electrolyte concentrations, osmolality, specific gravity, and sodium and potassium in urine.
- EligibilityCriteria: Inclusion Criteria:  body mass index (BMI) <35 kilgrams per square meter consistent dietary intake and exercise throughout study period consumes 2 liters (women) or 2.5 liters (men) of water per day prior to study visits able to fast for 15 hours  Exclusion Criteria:  sensitivity or be allergic to any components of the study product they will be excluded. tobacco user specialized diet (low carbohydrate/ketogenic diet, carnivore diet, intermittent fasting, etc.) caffeine consumption within 12 hours of study visit strenuous activity within 24 hours of study visit history or presence of a clinically relevant (that required or requires treatment) cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder conditions that alter fluid balance or electrolytes/hydration status consuming any medication which may alter fluid retention/electrolyte levels such as sodium-glucose co-transporter 2 (SGLT2) inhibitor (for type 2 diabetes), laxatives, diuretics, Apremilast, chemotherapy, or lithium. consuming nutritional supplements, performance enhancing drugs, and/or non-steroidal anti-inflammatory drugs within 7 days of study visits excluding screening). employee of Liquid IV be enrolled in another clinical study within 30 days of the first study visit active infection or illness of any kind - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 18 Years - MaximumAge: 45 Years - StdAgeList: Adult